
Sign up to save your podcasts
Or


Chief Cross-Asset Strategist Andrew Sheets and Biotech equity analyst Matthew Harrison continue their conversation, with a focus on international progress for COVID-19 vaccinations.
By Morgan Stanley4.8
12461,246 ratings
Chief Cross-Asset Strategist Andrew Sheets and Biotech equity analyst Matthew Harrison continue their conversation, with a focus on international progress for COVID-19 vaccinations.

1,713 Listeners

977 Listeners

406 Listeners

1,173 Listeners

2,175 Listeners

199 Listeners

686 Listeners

1,044 Listeners

191 Listeners

71 Listeners

80 Listeners

1,573 Listeners

435 Listeners

212 Listeners

118 Listeners

80 Listeners

0 Listeners